Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 27 Jan 2003 |
| Genmab, Genmab Achieves First Milestone in Roche Antibody Collaboration | 9 Jan 2003 |
| Genmab, GENMAB TO PRESENT AT JP MORGAN H&Q HEALTHCARE CONFERENCE 2003 | 6 Jan 2003 |
| Genmab, Financial Calendar 2003 | 18 Dec 2002 |
| Genmab, last day of trading of Genmab’s Co-Ownership Interests (COIS) at the Frankfurt Stock Exchange | 10 Dec 2002 |